Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | KCNQ3 | O43525 | 5/20 | 0.55 |
| ▸ | KCNQ2 | O43526 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | NAMPT | P43490 | 2/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.47 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14083313 | 0.92 | SMN1; SMN2 (0.64) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083686 | 0.90 | KCNQ3 (0.53) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083110 | 0.89 | KCNQ3 (0.72) | KCNQ3KCNQ2 | |
| SCHEMBL14084122 | 0.88 | TRPV1 (0.59) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083392 | 0.88 | SMN1; SMN2 (0.56) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083089 | 0.87 | MEN1 (0.51) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083096 | 0.87 | KCNQ3 (0.56) | KCNQ3KCNQ2MEN1KMT2ACASP3 | |
| SCHEMBL14083102 | 0.85 | TRPV1 (0.62) | SMN1; SMN2MAPT | |
| SCHEMBL14083098 | 0.85 | SMN1; SMN2 (0.59) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A | |
| SCHEMBL14083103 | 0.85 | TRPV1 (0.54) | SMN1; SMN2KCNQ3KCNQ2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200524-A1 | Amide compounds as ion channel ligands and uses thereof | KELLY MICHAEL G | 2008-08-21 | — | — | US | disclosed |
| US-20080200524-A1 | Amide compounds as ion channel ligands and uses thereof | KELLY MICHAEL G | 2008-08-21 | — | — | US | disclosed |
| US-7338950-B2 | Amide compounds as ion channel ligands and uses thereof | RENOVIS, INC. (US) | 2008-03-04 | — | — | US | disclosed |
| US-7338950-B2 | Amide compounds as ion channel ligands and uses thereof | RENOVIS, INC. (US) | 2008-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200524-A1 | Amide compounds as ion channel ligands and uses thereof | TRPV1, TRPA1, TRPV2 | SMN1; SMN2 2099/4885KCNQ3 87/4885KCNQ2 67/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.